Get it on Google Play

FDA lifts clinical hold on Tenaya's TN-201 gene therapy trial

December 11, 2025 4:01 PM EST Send to a Friend
Tenaya Therapeutics Inc. (NASDAQ: TNYA) announced that the U.S. Food and Drug Administration has removed the clinical hold on its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login